Microchemical Journal, Год журнала: 2024, Номер 207, С. 111969 - 111969
Опубликована: Окт. 22, 2024
Язык: Английский
Microchemical Journal, Год журнала: 2024, Номер 207, С. 111969 - 111969
Опубликована: Окт. 22, 2024
Язык: Английский
Colloids and Surfaces A Physicochemical and Engineering Aspects, Год журнала: 2024, Номер unknown, С. 135461 - 135461
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
4Chemical Science, Год журнала: 2024, Номер unknown
Опубликована: Янв. 1, 2024
Two-dimensional rare earth-containing nanomaterials are promising candidates in biomedical applications such as drug delivery, bio-imaging, antibacterial and cancer treatment due to their unique structure versatile energy levels.
Язык: Английский
Процитировано
3Talanta, Год журнала: 2024, Номер 282, С. 126973 - 126973
Опубликована: Окт. 2, 2024
Язык: Английский
Процитировано
3The Chemical Record, Год журнала: 2025, Номер unknown
Опубликована: Янв. 2, 2025
Triple-negative breast cancer (TNBC) represents a highly aggressive and prognostically unfavorable subtype of cancer, characterized by the absence common hormone receptors, which renders conventional therapies largely ineffective. This review comprehensively examines molecular clinical characteristics TNBC, underscoring substantial challenges inherent in its treatment innovative potential targeted nanoprobes advancing both diagnostic therapeutic paradigms. Through modification targeting molecules, can deliver agents specific to TNBC cells, thus significantly improving sensitivity modalities efficacy interventions. Our discussion systematically explores application various molecules their advantages limitations. In addition, this presents series multifunctional that are designed perform functions, providing synergistic approach TNBC. These advanced enable precise tumor localization while monitoring response real time, facilitating more personalized dynamic regimen. The major obstacles encountered during translation discussed detail. use leap forward medicine for current research efforts will continue refine these technologies improve applicability.
Язык: Английский
Процитировано
0Comments on Inorganic Chemistry, Год журнала: 2025, Номер unknown, С. 1 - 46
Опубликована: Янв. 22, 2025
Язык: Английский
Процитировано
0Environmental Research, Год журнала: 2025, Номер unknown, С. 121031 - 121031
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Chemical Papers, Год журнала: 2025, Номер unknown
Опубликована: Фев. 19, 2025
Язык: Английский
Процитировано
0Small, Год журнала: 2025, Номер unknown
Опубликована: Фев. 18, 2025
Abstract Using entire tumor cells or tissues that display both common and patient‐specific antigens can potentially trigger a comprehensive long‐lasting anti‐tumor immune response. However, the limited immunogenicity, low uptake efficiency, susceptibility to degradation of whole‐component present significant challenges. In this study, we employed lysates (TLs) as antigens, in conjunction with MgAl‐layered double hydroxide (MA) nanoadjuvants Mn 2+ immunostimulants, create personalized MMAT (Mn ‐MA‐TLs) nanovaccines. After subcutaneous injection nanovaccines, high local concentrations TLs facilitated recruitment activation antigen‐presenting (APCs), thereby inducing robust adaptive Remarkably, nanovaccines enabled lysosomal escape, enhanced antigen cross‐presentation, activated cyclic GMP‐AMP synthase (cGAS)‐stimulator interferon genes (STING) pathway APCs. Furthermore, when combined anti‐TIGIT monoclonal antibody (aTIGIT), an checkpoint inhibitor, not only stimulated T‐cell‐based responses but also NK‐cell‐based innate immunity, effectively suppressing growth, recurrence, metastasis. Thus, ternary developed here introduced pioneered paradigm for rapid preparation immunostimulants into offering new prospects clinical immunotherapies.
Язык: Английский
Процитировано
0Microchemical Journal, Год журнала: 2025, Номер unknown, С. 113711 - 113711
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Biosensors and Bioelectronics, Год журнала: 2024, Номер 268, С. 116926 - 116926
Опубликована: Ноя. 9, 2024
Язык: Английский
Процитировано
1